Coverage
-
November 12, 2015
A Pennsylvania federal judge on Tuesday again dismissed a proposed class action alleging defunct biotechnology firm Genaera Corp. shortchanged shareholders by undervaluing company assets sold through a liquidating trust, finding the majority of the revived claims don't show company directors breached duties owed to investors.
2 other articles on this case.
View all »